(1)
Khemla, S.; Meesing, A.; Sribenjalux, W.; Chetchotisakd, P. Lipid Profiles of People With Human Immunodeficiency Virus With Dyslipidemia After Switching from Efavirenz to Dolutegravir. dti 2023, 17, 45-53.